Literature DB >> 18568036

A second binding site for double-stranded RNA in TLR3 and consequences for interferon activation.

Nina Pirher1, Karolina Ivicak, Jelka Pohar, Mojca Bencina, Roman Jerala.   

Abstract

We show that substrate specificity of Toll-like receptor 3 (TLR3) is due to the presence of two binding sites in the ectodomain, separated by 50 A. This corresponds to two turns of a double-stranded RNA duplex, allowing differentiation between nucleic acids in the A- or B-type conformation. We propose that there are different arrangements of TLR3 ectodomains along the double-stranded RNA that could modulate the strength of the interferon response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18568036     DOI: 10.1038/nsmb.1453

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  35 in total

1.  A role for Toll-like receptor 3 variants in host susceptibility to enteroviral myocarditis and dilated cardiomyopathy.

Authors:  Carlos Gorbea; Kimberly A Makar; Matthias Pauschinger; Gregory Pratt; Jeathrina L F Bersola; Jacquelin Varela; Ryan M David; Lori Banks; Chien-Hua Huang; Hua Li; Heinz-Peter Schultheiss; Jeffrey A Towbin; Jesús G Vallejo; Neil E Bowles
Journal:  J Biol Chem       Date:  2010-05-14       Impact factor: 5.157

Review 2.  Extracellular RNA Sensing by Pattern Recognition Receptors.

Authors:  Megumi Tatematsu; Kenji Funami; Tsukasa Seya; Misako Matsumoto
Journal:  J Innate Immun       Date:  2018-11-07       Impact factor: 7.349

3.  Scavenger receptor SREC-I promotes double stranded RNA-mediated TLR3 activation in human monocytes.

Authors:  Ayesha Murshid; Jianlin Gong; Ridwan Ahmad; Thiago J Borges; Stuart K Calderwood
Journal:  Immunobiology       Date:  2014-12-30       Impact factor: 3.144

4.  Comprehensive modeling and functional analysis of Toll-like receptor ligand-recognition domains.

Authors:  Andriy V Kubarenko; Satish Ranjan; Elif Colak; Julie George; Martin Frank; Alexander N R Weber
Journal:  Protein Sci       Date:  2010-03       Impact factor: 6.725

5.  The role of UNC93B1 protein in surface localization of TLR3 receptor and in cell priming to nucleic acid agonists.

Authors:  Jelka Pohar; Nina Pirher; Mojca Benčina; Mateja Manček-Keber; Roman Jerala
Journal:  J Biol Chem       Date:  2012-11-19       Impact factor: 5.157

6.  Proteolytic processing regulates Toll-like receptor 3 stability and endosomal localization.

Authors:  Rongsu Qi; Divyendu Singh; C Cheng Kao
Journal:  J Biol Chem       Date:  2012-08-03       Impact factor: 5.157

Review 7.  TLR3 immunity to infection in mice and humans.

Authors:  Shen-Ying Zhang; Melina Herman; Michael J Ciancanelli; Rebeca Pérez de Diego; Vanessa Sancho-Shimizu; Laurent Abel; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2013-01-03       Impact factor: 7.486

8.  Short-interfering RNAs induce retinal degeneration via TLR3 and IRF3.

Authors:  Mark E Kleinman; Hiroki Kaneko; Won Gil Cho; Sami Dridi; Benjamin J Fowler; Alexander D Blandford; Romulo J C Albuquerque; Yoshio Hirano; Hiroko Terasaki; Mineo Kondo; Takashi Fujita; Balamurali K Ambati; Valeria Tarallo; Bradley D Gelfand; Sasha Bogdanovich; Judit Z Baffi; Jayakrishna Ambati
Journal:  Mol Ther       Date:  2011-10-11       Impact factor: 11.454

9.  Small interfering RNA-induced TLR3 activation inhibits blood and lymphatic vessel growth.

Authors:  Won Gil Cho; Romulo J C Albuquerque; Mark E Kleinman; Valeria Tarallo; Adelaide Greco; Miho Nozaki; Martha G Green; Judit Z Baffi; Balamurali K Ambati; Massimo De Falco; Jonathan S Alexander; Arturo Brunetti; Sandro De Falco; Jayakrishna Ambati
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-09       Impact factor: 11.205

10.  Activation of interferon regulatory factor-3 via toll-like receptor 3 and immunomodulatory functions detected in A549 lung epithelial cells exposed to misplaced U1-snRNA.

Authors:  Christian D Sadik; Malte Bachmann; Josef Pfeilschifter; Heiko Mühl
Journal:  Nucleic Acids Res       Date:  2009-06-18       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.